TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Nobel Biocare AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
635,184
|
563,609
|
492,140 |
Financial expenses |
14,838
|
28,584
|
16,826 |
Earnings before taxes |
27,662
|
34,131
|
12,495 |
EBITDA |
81,681
|
100,999
|
55,192 |
Total assets |
1,684,951
|
1,419,577
|
2,327,270 |
Current assets |
691,567
|
384,115
|
1,284,187 |
Current liabilities |
452,704
|
212,667
|
1,146,770 |
Equity capital |
1,215,644
|
1,193,538
|
1,167,049 |
- share capital |
317,186
![]() |
317,186
![]() |
317,186 |
Employees (average) |
345
|
364
|
350 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
72.1%
|
84.1%
|
50.1% |
Turnover per employee |
1,841
|
1,548
|
1,406 |
Profit as a percentage of turnover |
4.4%
|
6.1%
|
2.5% |
Return on assets (ROA) |
2.5%
|
4.4%
|
1.3% |
Current ratio |
152.8%
|
180.6%
|
112.0% |
Return on equity (ROE) |
2.3%
|
2.9%
|
1.1% |
Change turnover |
71,575
|
71,469
|
132,972 |
Change turnover % |
13%
|
15%
|
37% |
Chg. No. of employees |
-19
|
14
|
54 |
Chg. No. of employees % |
-5%
|
4%
|
18% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.